09/25/23

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: New Beat AML Sub-Study Examines the Efficacy of Using a Lower-Dose of Common Treatment in Patients with Newly Diagnosed AML

The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to compare a lower-than-standard dosage of a widely used treatment in newly diagnosed acute myeloid leukemia (AML) patients. This clinical trial is designed to evaluate the efficacy this dosage and treatment schedule of Venetoclax plus Azacitidine may have for newly diagnosed AML patients.

• Tags:
• Cancer Research,
• Clinical Trial,

Full story About: Clinical Trial Highlight: New Beat AML Sub-Study Examines the Efficacy of Using a Lower-Dose of Common Treatment in Patients with Newly Diagnosed AML

08/30/23

By: University of Cincinnati Cancer Center

Second Annual 'Updates on Hematology & Oncology Conference' Highlights Latest Cancer Research

• Tags:
• Cancer Research,
• Event,
• Professional Development,

Full story About: Second Annual 'Updates on Hematology & Oncology Conference' Highlights Latest Cancer Research

07/18/23

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: UCCC-BRE-21-01: Early Signatures of Vascular Aging in Women with Breast Cancer

• Tags:
• Breast Cancer,
• Clinical Trials,
• Exercise,
• Vascular Aging,

Full story About: Clinical Trial Highlight: UCCC-BRE-21-01: Early Signatures of Vascular Aging in Women with Breast Cancer

06/28/23

By: University of Cincinnati Cancer Center

Eight Cancer Researchers Receive Pilot Funding through the Cancer Center’s Spring Pilot Project Award Funding Cycle

• Tags:
• Grants,
• Pilot Grants,

Full story About: Eight Cancer Researchers Receive Pilot Funding through the Cancer Center’s Spring Pilot Project Award Funding Cycle

06/28/23

By: University of Cincinnati Cancer Center

Tammy Holm, MD, PhD Awarded ThyCa Award

• Tags:
• awards,
• Endocrine,
• Thyroid Cancer,

Full story About: Tammy Holm, MD, PhD Awarded ThyCa Award

06/26/23

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (Imvax 14379-201)

• Tags:
• Brain Cancer,
• Cancer Center,
• Clinical Trials,
• Immunotherapy,

Full story About: Clinical Trial Highlight: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (Imvax 14379-201)

05/31/23

By: University of Cincinnati Cancer Center

Survivorship Grant Awardees Spotlight - May 2023

• Tags:
• Cancer Center,
• Grants,
• Survivorship,

Full story About: Survivorship Grant Awardees Spotlight - May 2023

05/03/23

By: University of Cincinnati Cancer Center

Clinical Trial Highlight: UCCC-GI-21-01 Immunotherapy Prior to Liver Transplant for Hepatocellular Cancer (HCC)

• Tags:
• Cancer Center,
• Clinical Trials,
• Immunotherapy,
• Liver Cancer,

Full story About: Clinical Trial Highlight: UCCC-GI-21-01 Immunotherapy Prior to Liver Transplant for Hepatocellular Cancer (HCC)

04/30/23

By: University of Cincinnati Cancer Center

A Spotlight on Head & Neck Cancers at the Takiar & Wise-Draper Laboratory

• Tags:
• Cancer Center,
• Clinical Trials,
• Head & Neck Cancer,

Full story About: A Spotlight on Head & Neck Cancers at the Takiar & Wise-Draper Laboratory

03/31/23

By: University of Cincinnati Cancer Center

Clinical Trials at the University of Cincinnati Cancer Center

• Tags:

Full story About: Clinical Trials at the University of Cincinnati Cancer Center

03/31/23

By: University of Cincinnati Cancer Center

Susan Waltz, PhD name the next Associate Director for Cancer Research Training and Education Coordination

• Tags:
• CRTEC,

Full story About: Susan Waltz, PhD name the next Associate Director for Cancer Research Training and Education Coordination